Ostatní
Návod 
Cardinal Health, Inc.
CAH
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
48.2B
Obrat
244B
Zisk
2B
Aktiva
55B
Dluh
9B
ROE
0%
ROA
0%
PE
30
PS
0
Cena 1R
121-215
⌀ Cena
166.38
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
05-02-2026
Poslední dividenda
01-04-2026
Profil
Společnost Cardinal Health, Inc. působí jako integrovaná společnost poskytující zdravotnické služby a produkty ve Spojených státech, Kanadě, Evropě, Asii a na mezinárodní úrovni. Poskytuje přizpůsobená řešení pro nemocnice, zdravotnické systémy, lékárny, ambulantní chirurgická centra, klinické laboratoře, ordinace lékařů a pacienty v domácnosti. Společnost působí ve dvou segmentech, farmaceutickém a lékařském. Farmaceutický segment distribuuje značkové a generické farmaceutické, specializované farmaceutické a volně prodejné zdravotnické a spotřební produkty. Segment také poskytuje služby farmaceutickým výrobcům a poskytovatelům zdravotní péče pro specializované farmaceutické výrobky, provozuje jaderné lékárny a zařízení pro výrobu radiofarmaka, přebaluje generická léčiva a volně prodejné zdravotnické výrobky a nabízí řízení léčebné terapie a služby v oblasti výstupů pacientů nemocnicím, dalším poskytovatelům zdravotní péče a plátcům a také poskytuje nemocnicím služby v oblasti řízení farmacie. Zdravotnický segment vyrábí, dodává a distribuuje zdravotnické, chirurgické a laboratorní produkty a přístroje značky Cardinal Health, které zahrnují testovací a chirurgické rukavice; jehly, stříkačky a odstraňování ostrých předmětů; komprese; inkontinence; produkty pro výživu; přípravky pro péči o rány; chirurgické roušky, pláště a oděvy na jedno použití; systémy odsávání a sběru tekutin; urologické produkty; produkty pro operační sály; a produktové řady elektrod. Segment také distribuuje řadu národních značkových produktů, včetně zdravotnických, chirurgických a laboratorních produktů; poskytuje služby dodavatelského řetězce a řešení nemocnicím, ambulantním chirurgickým centrům, klinickým laboratořím a dalším poskytovatelům zdravotní péče; a sestavuje a prodává sterilní a nesterilní léčebné soupravy. Společnost byla založena v roce 1979 a sídlí v Dublinu v Ohiu.
Sektor
Healthcare
Odvětví
Medical - Distribution
Počet zaměstnanců
47922
Založení
1983-08-04
Podobné společnosti
$ 177.84
- $ 0.07
$ 83.48
+ $ 0.09
$ 146.16
- $ 0.58
$ 9.54
+ $ 0.08
$ 211.92
+ $ 1.46
$ 294.08
- $ 0.79
$ 248.57
- $ 2.92
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 244.5 | 222.6 | 226.8 | 205.0 | 181.4 | 162.5 | 152.9 | 145.5 | 136.8 | 130.0 | 121.5 | 102.5 | 91.1 | 101.1 | 107.6 | 102.6 | 98.5 | |
| Cost of Revenues | 235.6 | 214.4 | 219.4 | 198.1 | 174.8 | 155.7 | 146.1 | 138.7 | 129.6 | 123.4 | 115.0 | 96.8 | 85.9 | 96.2 | 103.0 | 98.5 | 94.7 | |
| Gross Profit | 8.9 | 8.2 | 7.4 | 6.9 | 6.5 | 6.8 | 6.9 | 6.8 | 7.2 | 6.5 | 6.5 | 5.7 | 5.2 | 4.9 | 4.5 | 4.2 | 3.8 |
| Revenue | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 65.4 | 64.0 | 60.2 | 54.9 | 55.3 | 52.3 | 59.7 | 54.9 | 57.4 | 54.7 | |
| Cost of Revenues | 63.2 | 61.7 | 58.0 | 52.8 | 53.3 | 50.4 | 57.9 | 52.9 | 55.6 | 52.9 | |
| Gross Profit | 2.2 | 2.3 | 2.2 | 2.1 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 4.8 | 4.6 | 4.5 | 4.6 | 4.5 | 4.6 | 3.8 | 3.6 | 3.2 | 3.0 | 2.9 | 2.7 | 2.6 | 2.3 | |
| Depreciation & Amortization | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 0.7 | 1.0 | 0.7 | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | |
| Total Operating Expenses | 6.3 | 5.9 | 6.2 | 5.1 | 4.9 | 5.0 | 5.1 | 5.1 | 5.3 | 4.3 | 4.1 | 3.5 | 3.3 | 3.0 | 2.7 | 2.6 | 2.3 | |
| Operating Income | 2.5 | 2.3 | 1.2 | 0.7 | 1.6 | 1.8 | 1.8 | 2.1 | 0.1 | 2.1 | 2.5 | 2.2 | 1.9 | 1.0 | 1.8 | 1.5 | 1.3 |
| Operating Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | ||
| Total Operating Expenses | 1.5 | 1.7 | 1.8 | 1.4 | 1.4 | 1.3 | 1.4 | 1.6 | 1.3 | 1.8 | ||
| Operating Income | 0.7 | 0.7 | 0.4 | 0.7 | 0.5 | 0.6 | 0.4 | 0.4 | 0.5 | 0.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Other Expense | -0.3 | -0.2 | 0.0 | -0.1 | -2.4 | -1.5 | -5.5 | -0.3 | -1.8 | -0.1 | 0.0 | -0.1 | 0.0 | -0.9 | 0.0 | 0.0 | -0.1 | |
| IBT | 2.3 | 2.1 | 1.2 | 0.6 | -0.8 | 0.3 | -3.8 | 1.8 | -0.2 | 1.9 | 2.3 | 2.0 | 1.8 | 0.9 | 1.7 | 1.5 | 1.2 | |
| Income Tax Expense | 0.6 | 0.5 | 0.3 | 0.4 | 0.2 | -0.3 | -0.1 | 0.4 | -0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Net Income | 1.7 | 1.6 | 0.9 | 0.3 | -0.9 | 0.6 | -3.7 | 1.4 | 0.3 | 1.3 | 1.4 | 1.2 | 1.2 | 0.3 | 1.1 | 1.0 | 0.6 |
| Net Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | -0.1 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| IBT | 0.6 | 0.6 | 0.4 | 0.7 | 0.5 | 0.5 | 0.4 | 0.3 | 0.5 | 0.0 | ||
| Income Tax Expense | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | ||
| Net Income | 0.5 | 0.5 | 0.2 | 0.5 | 0.4 | 0.4 | 0.2 | 0.3 | 0.4 | 0.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $1.00 | $-3.34 | $2.09 | $-12.60 | $4.54 | $0.82 | $4.06 | $4.36 | $3.66 | $3.42 | $0.98 | $3.10 | $2.75 | $1.79 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $1.00 | $-3.34 | $2.08 | $-12.60 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | $3.38 | $0.97 | $3.06 | $2.72 | $1.77 | |
| Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | |
| Diluted Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 |
| Per Share Data | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | ||
| Diluted Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 5.1 | 3.9 | 5.1 | 4.0 | 4.7 | 3.4 | 2.8 | 2.5 | 1.8 | 6.9 | 2.4 | 4.6 | 2.9 | 1.9 | 2.3 | 1.9 | 2.8 | |
| Short Term Investments | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 5.1 | 3.9 | 5.1 | 4.0 | 4.7 | 3.4 | 2.8 | 2.5 | 1.8 | 6.9 | 2.4 | 4.6 | 2.9 | 1.9 | 2.3 | 1.9 | 2.8 | |
| Accounts Receivable | 12.1 | 13.2 | 12.1 | 11.1 | 10.6 | 9.1 | 8.3 | 8.4 | 7.8 | 8.0 | 7.4 | 6.5 | 5.4 | 6.3 | 6.4 | 6.2 | 5.2 | |
| Inventory | 15.0 | 16.8 | 15.0 | 15.9 | 15.6 | 14.6 | 13.2 | 12.8 | 12.3 | 11.3 | 10.6 | 9.2 | 8.3 | 8.4 | 7.9 | 7.3 | 6.4 | |
| Other Current Assets | 7.8 | 2.4 | 2.7 | 2.4 | 2.0 | 3.9 | 1.7 | 1.9 | 2.7 | 2.1 | 1.6 | 1.4 | 1.4 | 1.2 | 1.0 | 0.9 | 0.6 | |
| Total Current Assets | 34.9 | 36.4 | 34.9 | 33.8 | 32.9 | 31.0 | 25.9 | 25.7 | 24.6 | 28.3 | 22.0 | 21.8 | 17.9 | 17.8 | 17.5 | 16.3 | 14.9 |
| Current Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 4.6 | 3.9 | 3.3 | 3.8 | 2.9 | 5.1 | 3.7 | 4.6 | 3.9 | 4.0 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 4.6 | 3.9 | 3.3 | 3.8 | 2.9 | 5.1 | 3.7 | 4.6 | 3.9 | 4.0 | |
| Accounts Receivable | 13.8 | 13.2 | 12.7 | 12.4 | 11.8 | 12.1 | 11.6 | 11.8 | 11.3 | 11.3 | |
| Inventory | 17.6 | 16.8 | 16.2 | 16.9 | 15.6 | 15.0 | 17.3 | 18.5 | 17.0 | 15.9 | |
| Other Current Assets | 2.6 | 2.4 | 2.4 | 2.7 | 2.6 | 2.7 | 3.2 | 2.8 | 2.6 | 2.4 | |
| Total Current Assets | 38.5 | 36.4 | 34.6 | 35.8 | 32.9 | 34.9 | 35.7 | 37.7 | 34.7 | 33.8 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.0 | 2.9 | 2.5 | 2.5 | 2.4 | 2.4 | 2.4 | 2.4 | 2.5 | 1.9 | 1.8 | 1.5 | 1.5 | 1.5 | 1.6 | 1.5 | 1.5 | |
| Goodwill | 4.7 | 9.7 | 4.7 | 4.6 | 5.9 | 8.0 | 8.4 | 8.4 | 8.3 | 7.2 | 7.2 | 5.1 | 4.9 | 4.6 | 4.0 | 0.0 | 0.0 | |
| Intangible Assets | 1.7 | 2.5 | 1.7 | 1.5 | 1.8 | 2.1 | 2.9 | 3.4 | 3.9 | 2.0 | 2.3 | 0.9 | 1.0 | 1.0 | 0.4 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | -8.7 | 0.0 | -9.7 | -8.6 | -2.9 | -3.0 | -2.9 | -2.8 | -1.4 | -1.3 | -1.6 | -1.4 | -1.5 | 0.7 | |
| Other Long-Term Assets | 0.7 | 1.7 | 1.2 | 1.0 | -8.3 | 1.0 | 1.2 | 1.1 | 0.7 | 0.7 | 0.9 | 0.9 | 0.8 | 1.0 | 0.8 | 0.8 | -0.6 | |
| Total Long-Term Assets | 10.2 | 16.7 | 10.2 | 9.6 | 10.9 | 13.4 | 14.8 | 15.2 | 15.4 | 11.8 | 12.2 | 8.4 | 8.1 | 8.0 | 6.8 | 6.5 | 5.1 | |
| Total Assets | 45.1 | 53.1 | 45.1 | 43.4 | 43.9 | 44.5 | 40.8 | 41.0 | 40.0 | 40.1 | 34.1 | 30.1 | 26.0 | 25.8 | 24.3 | 22.8 | 20.0 |
| Long-Term Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.8 | 2.9 | 2.7 | 2.6 | 2.5 | 2.5 | 2.5 | 2.4 | 2.4 | 2.5 | |
| Goodwill | 9.7 | 9.7 | 8.9 | 5.5 | 4.7 | 4.7 | 4.8 | 4.0 | 4.0 | 4.6 | |
| Intangible Assets | 2.4 | 2.5 | 2.1 | 1.9 | 1.7 | 1.7 | 1.7 | 1.3 | 1.4 | 1.5 | |
| Long-Term Investments | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.7 | |
| Other Long-Term Assets | 1.8 | 1.7 | 1.5 | 1.3 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.0 | |
| Total Long-Term Assets | 16.7 | 16.7 | 15.3 | 11.2 | 10.2 | 10.2 | 10.1 | 8.9 | 9.0 | 9.6 | |
| Total Assets | 55.2 | 53.1 | 49.9 | 47.0 | 43.1 | 45.1 | 45.9 | 46.6 | 43.7 | 43.4 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 31.8 | 34.7 | 31.8 | 29.9 | 27.1 | 23.7 | 21.4 | 21.5 | 19.7 | 17.9 | 17.3 | 14.4 | 12.1 | 12.3 | 11.7 | 11.3 | 9.5 | |
| Short-Term Debt | 0.6 | 0.7 | 0.6 | 0.8 | 0.6 | 0.9 | 0.0 | 0.5 | 1.0 | 1.3 | 0.6 | 0.3 | 0.8 | 0.2 | 0.5 | 0.3 | 0.2 | |
| Other Current Liabilities | 3.3 | 3.5 | 3.4 | 3.0 | 2.8 | 0.1 | 2.2 | 2.1 | 0.2 | 2.0 | 1.8 | 2.6 | 2.2 | 2.1 | 2.0 | 1.7 | 1.8 | |
| Current Liabilities | 35.6 | 38.9 | 35.6 | 33.7 | 30.6 | 27.6 | 23.6 | 24.1 | 22.9 | 21.2 | 19.7 | 17.2 | 15.1 | 14.6 | 14.2 | 13.4 | 11.5 |
| Current Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 36.9 | 34.7 | 32.8 | 31.3 | 30.4 | 31.8 | 32.1 | 34.3 | 31.5 | 29.9 | |
| Short-Term Debt | 0.1 | 0.7 | 0.5 | 0.5 | 0.9 | 0.6 | 1.2 | 1.2 | 0.8 | 0.8 | |
| Other Current Liabilities | 3.4 | 3.5 | 3.3 | 3.4 | 3.4 | 3.4 | 3.0 | 2.8 | 2.7 | 3.0 | |
| Current Liabilities | 40.3 | 38.9 | 36.7 | 35.2 | 34.7 | 35.6 | 36.3 | 38.3 | 35.1 | 33.7 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 4.6 | 8.6 | 5.1 | 3.9 | 4.7 | 5.4 | 6.8 | 7.6 | 8.0 | 9.1 | 5.0 | 5.2 | 3.2 | 3.7 | 2.4 | 2.2 | 1.9 | |
| Capital Leases | 0.5 | 8.0 | 0.5 | 3.9 | 4.7 | 5.4 | 6.8 | 7.6 | 8.0 | 9.1 | 5.0 | 5.2 | 3.2 | 3.7 | 2.4 | 2.2 | 1.9 | |
| Def. Tax Liability | 3.1 | 2.4 | 3.1 | 8.7 | 9.3 | 9.7 | 8.6 | 2.9 | 3.0 | 2.9 | 2.8 | 1.4 | 1.3 | 1.6 | 1.4 | 1.5 | 1.3 | |
| Total Liabilities | 48.3 | 55.8 | 48.3 | 46.3 | 44.6 | 42.7 | 39.0 | 34.6 | 33.9 | 33.3 | 27.6 | 23.9 | 19.6 | 19.8 | 18.0 | 17.0 | 14.7 |
| Long-Term Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 9.0 | 8.6 | 7.1 | 7.1 | 4.2 | 5.1 | 4.7 | 3.5 | 3.9 | 3.9 | |
| Capital Leases | 9.0 | 8.0 | 7.1 | 7.1 | 4.2 | 0.5 | 4.7 | 3.5 | 3.9 | 3.9 | |
| Def. Tax Liability | 8.7 | 2.4 | 0.0 | 0.0 | 0.0 | 3.1 | 0.0 | 0.0 | 8.2 | 8.7 | |
| Total Liabilities | 58.0 | 55.8 | 51.8 | 49.9 | 46.3 | 48.3 | 49.1 | 50.0 | 47.2 | 46.3 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.9 | 3.0 | 2.9 | 2.7 | 2.8 | 2.8 | 2.8 | 2.8 | 2.7 | 2.7 | 3.0 | 3.0 | 3.0 | 3.0 | 2.9 | -0.5 | 2.9 | |
| Retained Earnings | -0.3 | 0.8 | -0.3 | -0.5 | -0.3 | 1.2 | 1.2 | 5.4 | 4.6 | 5.0 | 6.4 | 5.5 | 4.8 | 4.0 | 4.1 | 3.3 | 2.6 | |
| Comprehensive Income | -0.2 | -0.2 | -0.2 | -0.2 | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | |
| Total Common Equity | -3.2 | -2.8 | -3.2 | -2.9 | -0.7 | 1.8 | 1.8 | 6.3 | 6.1 | 6.8 | 6.6 | 6.3 | 6.4 | 6.0 | 6.2 | 5.8 | 5.3 |
| Total Common Equity | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.7 | 3.0 | 2.9 | 2.9 | 2.8 | 2.9 | 2.9 | 2.9 | 2.7 | 2.7 | |
| Retained Earnings | 1.1 | 0.8 | 0.7 | 0.3 | 0.0 | -0.3 | -0.3 | -0.4 | -0.7 | -0.5 | |
| Comprehensive Income | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | |
| Total Common Equity | -2.9 | -2.8 | -2.9 | -3.0 | -3.3 | -3.2 | -3.3 | -3.4 | -3.5 | -2.9 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 5.6 | 9.3 | 5.6 | 4.7 | 5.3 | 6.2 | 6.8 | 8.0 | 9.0 | 10.4 | 5.5 | 5.5 | 4.0 | 3.9 | 2.9 | 2.5 | 2.1 | |
| Book Value | -3.2 | -2.6 | -3.2 | -2.9 | -0.7 | 1.8 | 1.8 | 6.3 | 6.1 | 6.8 | 6.6 | 6.3 | 6.4 | 6.0 | 6.2 | 5.8 | 5.3 |
| Other | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.1 | 0.1 | 1.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -2.9 | -2.8 | -2.9 | -3.0 | -3.3 | -3.2 | -3.3 | -3.4 | -3.5 | -2.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.9 | 1.6 | 0.9 | 0.3 | -0.9 | 0.6 | -3.7 | 1.4 | 0.3 | 1.3 | 1.4 | 1.2 | 1.2 | 0.3 | 1.1 | 1.0 | 0.6 | |
| Depreciation & Amortization | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | |
| Stock-Based Compensation | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Change Working Capital | 1.5 | -0.5 | 1.5 | 0.5 | 1.1 | 0.3 | 6.1 | 0.8 | 0.9 | -1.3 | 0.6 | 0.5 | 0.8 | 0.0 | -0.4 | -0.1 | 0.9 | |
| Change In Accounts Receivable | -1.0 | -0.8 | -1.0 | -0.9 | -1.5 | -0.9 | 0.1 | -0.8 | -0.9 | -0.7 | -0.9 | -0.9 | 0.9 | 0.2 | -0.1 | -0.5 | 0.0 | |
| Change In Accounts Payable | 1.8 | 2.7 | 1.8 | 2.7 | 3.4 | 2.3 | -0.2 | 1.9 | 2.6 | 0.6 | 2.8 | 1.9 | -0.2 | 0.4 | 0.3 | 1.4 | 0.5 | |
| Change In Inventories | 1.1 | -1.8 | 1.1 | -0.3 | -1.1 | -1.6 | -0.4 | -0.6 | -1.2 | -0.7 | -1.2 | -0.8 | 0.1 | -0.4 | -0.5 | -0.7 | 0.5 | |
| Other Non-cash Items | 1.7 | 0.1 | 0.7 | 1.4 | 2.2 | 0.2 | -0.5 | -0.4 | 1.5 | 0.1 | 0.1 | 0.1 | 0.0 | 0.9 | 0.0 | 0.0 | 0.2 | |
| Cash from Operations | 3.8 | 0.0 | 0.0 | 2.8 | 3.1 | 2.4 | 2.0 | 2.7 | 2.8 | 1.2 | 3.0 | 2.5 | 2.5 | 1.7 | 1.2 | 1.4 | 2.1 |
| Cash Flow From Operating Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.5 | 0.5 | 0.2 | 0.5 | 0.4 | 0.4 | 0.2 | 0.3 | 0.4 | 0.0 | |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Stock-Based Compensation | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change Working Capital | -0.2 | 0.2 | 0.6 | 2.2 | -1.0 | -2.3 | 1.7 | -0.6 | 0.6 | -0.2 | |
| Change In Accounts Receivable | 0.3 | -0.5 | -0.5 | -0.1 | -0.5 | 0.3 | -0.7 | 0.3 | -0.5 | 0.1 | |
| Change In Accounts Payable | 2.0 | 2.1 | 1.8 | 1.4 | 0.9 | -1.4 | -0.5 | -2.2 | 2.6 | 1.8 | |
| Change In Inventories | -3.2 | -0.7 | -0.6 | 0.8 | -1.3 | -0.7 | 2.5 | 1.2 | -1.4 | -1.1 | |
| Other Non-cash Items | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.0 | 0.6 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.5 | -0.5 | -0.5 | -0.5 | -0.4 | -0.4 | -0.4 | -0.3 | -0.4 | -0.4 | -0.5 | -0.3 | -0.2 | -0.2 | -0.3 | -0.3 | -0.3 | |
| Acquisitions | -1.2 | -5.3 | -1.2 | 0.0 | 0.9 | 0.0 | 0.0 | 0.7 | -5.3 | -0.1 | -3.6 | -0.5 | -0.5 | -2.2 | -0.2 | -2.3 | 0.0 | |
| Investments | -0.6 | 0.0 | -0.6 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.2 | -0.3 | -0.1 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Sales of Investment | 0.4 | 0.2 | 0.4 | 0.0 | 0.1 | 0.0 | 0.9 | 0.0 | 0.1 | 0.3 | 0.2 | 0.2 | 0.0 | 0.1 | 0.1 | 0.7 | 0.3 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Cash from Investing | -1.8 | 0.0 | 0.0 | -0.5 | 0.6 | -0.4 | 0.5 | 0.3 | -5.6 | -0.4 | -4.1 | -0.8 | -0.9 | -2.4 | -0.4 | -2.0 | 0.1 |
| Cash Flow From Investing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | -0.1 | |
| Acquisitions | -1.9 | 0.0 | -1.4 | -2.8 | -1.1 | 0.0 | 0.0 | -1.2 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.6 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.9 | 0.0 | 0.0 | -0.6 | -0.9 | -0.6 | -1.4 | -1.1 | -1.0 | -0.3 | 0.0 | -1.2 | 0.0 | -0.3 | -0.3 | -0.2 | -1.6 | |
| Debt Issued | 2.8 | 3.7 | 0.9 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | -0.4 | 5.2 | 0.1 | 2.7 | 0.1 | 1.3 | 0.6 | 0.6 | 3.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.2 | 0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Repurchase of Common Stock | -0.8 | -0.8 | -0.8 | -2.0 | -1.0 | -0.2 | -0.4 | -0.6 | -0.6 | -0.6 | -0.7 | -1.0 | -0.7 | -0.5 | -0.5 | -0.3 | -0.2 | |
| Dividends Paid | -0.5 | 0.0 | 0.0 | -0.5 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 | -0.5 | -0.5 | -0.4 | -0.4 | -0.3 | -0.3 | -0.3 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | -0.1 | 0.1 | 0.0 | 2.7 | 0.2 | 1.3 | 0.5 | 0.5 | 1.3 | |
| Cash from Financing | -0.8 | 0.0 | 0.0 | -3.1 | -2.5 | -1.3 | -2.2 | -2.3 | -2.3 | 3.7 | -1.1 | 0.1 | -0.7 | 0.3 | -0.5 | -0.2 | -0.7 |
| Cash Flow From Financing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 9.0 | -0.3 | 1.7 | 0.1 | 2.4 | -0.4 | -0.2 | 1.1 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.4 | -0.4 | 0.8 | -0.4 | 0.0 | -0.4 | 0.0 | 0.0 | -0.3 | -0.5 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1.1 | -1.3 | 1.1 | -0.7 | 1.3 | 0.6 | 0.2 | 0.8 | -5.1 | 4.5 | -2.3 | 1.8 | 1.0 | -0.4 | 0.3 | -0.8 | 1.5 | |
| Closing Cash Balance | 5.1 | 3.9 | 5.1 | 4.0 | 4.7 | 3.4 | 2.8 | 2.5 | 1.8 | 6.9 | 2.4 | 4.6 | 2.9 | 1.9 | 2.3 | 1.9 | 2.8 |
| Cash position | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -1.8 | 0.7 | 0.5 | -0.5 | 0.9 | -2.3 | 1.4 | -0.9 | 0.7 | -0.2 | |
| Closing Cash Balance | 2.8 | 4.6 | 3.9 | 3.3 | 3.8 | 2.9 | 5.1 | 3.7 | 4.6 | 3.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.3 | 1.9 | 3.3 | 2.4 | 2.7 | 2.0 | 1.6 | 2.4 | 2.4 | 0.8 | 2.5 | 2.2 | 2.3 | 1.5 | 0.9 | 1.1 | 1.9 | |
| Real Free Cash Flow | 3.1 | 1.6 | 3.1 | 2.3 | 2.7 | 1.9 | 1.5 | 2.3 | 2.3 | 0.7 | 2.4 | 2.1 | 2.2 | 1.4 | 0.8 | 1.0 | 1.8 |
| Free Cash Flow | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.6 | 0.9 | 1.3 | 2.8 | -0.5 | -1.7 | 1.9 | -0.1 | 1.1 | 0.4 | |
| Real Free Cash Flow | 0.5 | 0.8 | 1.1 | 2.8 | -0.5 | -1.8 | 1.9 | -0.2 | 1.0 | 0.4 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 29.6 | 83.3 | 29.6 |
| P/S | 0.2 | 0.2 | 2 |
| P/B | -18 | 0.8 | 20.1 |
| P/FCF | 9.6 | 12.1 | 96.2 |
| Market cap | $48.2 | $28.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 14.8 % | 0 % |
| Debt to Income | 542.1 % | 4643.8 % | 0 % |
| Debt to Free cash flow | 175.7 % | 46.7 % | 0 % |
| Interest expense percentage | 12.5 % | 20.9 % | 12.9 % |
| Current ratio | 1 | 1.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -57.9 % | -6.4 % | 0 % |
| ROA | 3 % | 1.7 % | 0 % |
| CapEx to Revenue | 0.2 % | 0.3 % | 0.9 % |
| RaD to Revenue | 0 % | 0 % | 0 % |
| ROEM | 4,237,209.7 | 3946913.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 3.6 % | 4.4 % | 56.4 % |
| Operating margin | 1 % | 0.9 % | 29.2 % |
| Net margin | 0.7 % | 0.5 % | 16.9 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.4 % | 0 % |
| Dividend payout percentage | 0 % | 36.9 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 237.0 mil | 308.1 mil |
| Employee count | 57.7 tis | 32.9 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
